Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial
Open accessThe DOI matches its Crossref record; 63 of the 65 references it cites were found in a registry or an index; 10 of the 41 sources its claims cite were checked for support.
Abstract
This randomized, placebo-controlled, crossover, and double-blind trial aimed to examine the possible effects of four weeks L-theanine administration on stress-related symptoms and cognitive functions in healthy adults. Participants were 30 individuals (nine men and 21 women; age: 48.3 ± 11.9 years) who had no major psychiatric illness. L-theanine (200 mg/day) or placebo tablets were randomly and blindly assigned for four-week administration. For stress-related symptoms, Self-rating Depression Scale, State-Trait Anxiety Inventory-trait, and Pittsburgh Sleep Quality Index (PSQI) scores decreased after L-theanine administration (p = 0.019, 0.006, and 0.013, respectively). The PSQI subscale scores for sleep latency, sleep disturbance, and use of sleep medication reduced after L-theanine administration, compared to the placebo administration (all p < 0.05). For cognitive functions, verbal fluency and executive function scores improved after L-theanine administration (p = 0.001 and 0.031, respectively). Stratified analyses revealed that scores for verbal fluency (p = 0.002), especially letter fluency (p = 0.002), increased after L-theanine administration, compared to the placebo administration, in individuals who were sub-grouped into the lower half by the median split based on the mean pretreatment scores. Our findings suggest that L-theanine has the potential to promote mental health in the general population with stress-related ailments and cognitive impairments.
Overview
CoChat Summary
TL;DR
In a randomized, placebo-controlled, double-blind crossover trial of 30 healthy adults, four weeks of L-theanine (200 mg/day) improved some stress-related symptom scores and cognitive scores, especially verbal fluency in participants with lower baseline performance. L-theanine was safe and well tolerated, but effects versus placebo were limited to certain PSQI subscales and verbal fluency.
Key findings
- SDS, STAI-trait, and PSQI scores decreased after L-theanine administration (p = 0.019, 0.006, and 0.013, respectively); PSQI sleep latency and daytime dysfunction also improved (p = 0.036 and 0.022), with no significant changes after placebo.
- Compared with placebo, reductions were greater for PSQI sleep latency, sleep disturbance, and use of sleep medication (p = 0.0499, 0.046, and 0.047), while SDS and PSQI changes showed non-significant trends (p = 0.084 and 0.073).
- BACS verbal fluency and executive function improved after L-theanine (p = 0.001 and 0.031); in the lower half by median split, verbal fluency and letter fluency improved more than placebo (both p = 0.002), with executive function trending (p = 0.062).
- Serum L-theanine increased after L-theanine (p = 0.002) and differed from placebo (p = 0.028); no other biochemical indices changed significantly, and no adverse events or dropouts occurred.
Methods
- Thirty adults (9 men, 21 women; mean age 48.3 ± 11.9 years, range 20–69) without major psychiatric illness were randomized to 200 mg/day L-theanine or placebo before sleep for four weeks, then crossed over after a two-week washout.
- Assessments at baseline and weeks 4, 6, and 10 included SDS, STAI, PSQI, Trail-Making Test, Stroop test, BACS, and blood/saliva laboratory measures including serum L-theanine.
- Within-condition changes used Wilcoxon signed-rank tests; between-condition changes used Mann-Whitney U tests with r effect sizes; BACS scores were stratified by median split of mean pretreatment scores; two-tailed p < 0.05 was significant.
Limitations
- The paper states: real-world setting with unaccounted biases (tea consumption, medicine, diet, nutrients, work); only about 20% of symptom and cognitive measures changed significantly versus placebo, suggesting limited daily-function effects; participants had no psychiatric disorders, so effects may be inconspicuous; small n = 30 may be insufficient and subject to type II errors; wider age range and both sexes were included due to lack of solid information on specific subgroups.
- The paper also notes that compliance was checked only verbally and usual green tea or other L-theanine-containing beverage intake was not tracked.
- Evident from the text: no correction for multiple comparisons is reported, and Trail Making Test A and B improved significantly after placebo (p = 0.042 and 0.038), which complicates attribution of cognitive changes.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
8 Valid · 1 Not valid · 4 Not checked · 58 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“To our knowledge, however, only its acute effects have been investigated in healthy individuals.”
- Also stated in: § 1. Introduction · plain
“With the except of Hidese et al. [40], most human studies have focused on the effects of acute L-theanine administration.”
§ Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial > 1. Introduction
What the sources say
- Not checked — no full text of the sourcecites [33] Kimura K. Ozeki M. Juneja L.R. Ohira H. l-theanine reduces psychological and physiological stress responses Biol. Psychol. 2007 74 39 45 10.1016/j.biopsycho.2006.06.006 16930802 source
- Disputedcites [34] White D.J. de Klerk S. Woods W. Gondalia S. Noonan C. Scholey A.B. Anti-stress, behavioural and magnetoencephalography effects of an l-theanine-based nutrient drink: A randomised, double-blind, placebo-controlled, crossover trial Nutrients 2016 8 53 10.3390/nu8010053 26797633 PMC4728665 sourceExperimental — accuracy not yet measured
The Discussion (page not specified) explicitly reports a study of chronic l-theanine administration in undergraduate students, including a one-week run-in. That contradicts the claim that only acute effects have been investigated in healthy individuals. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [35] Unno K. Tanida N. Ishii N. Yamamoto H. Iguchi K. Hoshino M. Takeda A. Ozawa H. Ohkubo T. Juneja L.R. Anti-stress effect of theanine on students during pharmacy practice: Positive correlation among salivary α-amylase activity, trait anxiety and subjective stress Pharmacol. Biochem. Behav. 2013 111 128 135 10.1016/j.pbb.2013.09.004 24051231 source
- Not checked — no full text of the sourcecites [36] Foxe J.J. Morie K.P. Laud P.J. Rowson M.J. de Bruin E.A. Kelly S.P. Assessing the effects of caffeine and theanine on the maintenance of vigilance during a sustained attention task Neuropharmacology 2012 62 2320 2327 10.1016/j.neuropharm.2012.01.020 22326943 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 1. Introduction · plain
Every source the paper cites for this claim was checked and supports it.
In the paper
“The current sample (30 L-theanine and 30 placebo) had a power of> 0.80, based on the effect size (0.61) of L-theanine on depression score in our previous study [40].”
§ Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial > 2. Materials and Methods > 2.1. Participants
What the sources say
- Supportedcites [40] Hidese S. Ota M. Wakabayashi C. Noda T. Ozawa H. Okubo T. Kunugi H. Effects of chronic l-theanine administration in patients with major depressive disorder: An open-label study Acta Neuropsychiatr. 2017 29 72 79 10.1017/neu.2016.33 27396868 source
The Results report an effect size of r = −0.61 for the decrease in HAMD-21 depression scores, supporting the previous-study value cited. The 30-per-group sample and >0.80 power are calculations about the citing study, not findings attributed to this source. (LLM, conf=0.92)
plainn = 30- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In accordance with this, we have reported multiple favourable effects of four weeks L-theanine administration (250 mg/day) in patients with major depressive disorder (MDD), although this was an open-label study [40].”
§ Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial > 1. Introduction
What the sources say
- Partly supportedcites [40] Hidese S. Ota M. Wakabayashi C. Noda T. Ozawa H. Okubo T. Kunugi H. Effects of chronic l-theanine administration in patients with major depressive disorder: An open-label study Acta Neuropsychiatr. 2017 29 72 79 10.1017/neu.2016.33 27396868 sourceExperimental — accuracy not yet measured
The L-theanine administration section describes an open-label study in patients with MDD using 250 mg/day, and the Discussion reports multiple favourable effects. But treatment lasted eight weeks, not four; the Statistics section says the reported comparisons were between baseline and eight weeks. Four-week measurements were recorded, but they do not support describing this as a four-week study. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition to the possible efficacy in the treatment of clinical depression [40], the present study suggests that L-theanine may be a psychoactive reagent broadly useful to improve mental health in humans.”
§ Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial > 4. Discussion
What the sources say
- Supportedcites [40] Hidese S. Ota M. Wakabayashi C. Noda T. Ozawa H. Okubo T. Kunugi H. Effects of chronic l-theanine administration in patients with major depressive disorder: An open-label study Acta Neuropsychiatr. 2017 29 72 79 10.1017/neu.2016.33 27396868 source
The citation is attached to the possible efficacy of L-theanine for clinical depression, not to the citing authors’ broader conclusion about mental health. In the Discussion, the source reports reduced depressive symptoms after L-theanine administration in patients with major depressive disorder, while noting that its study was open-label and the reduction was seen in patients unremitted at baseline. That supports the citing sentence’s qualified wording, “possible efficacy.” (LLM, conf=0.92)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Stratified analyses revealed that scores for verbal fluency (p = 0.002), especially letter fluency (p = 0.002), increased after L-theanine administration, compared to the placebo administration, in individuals who were sub-grouped into the lower half by the median split based on the mean pretreatment scores.”
§ Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
41 more claims
Create a free account to see all 71 claims and every source verdict.
- It may state two separate claims as one. 15
- Probably not a substantial claim. 13
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, a randomized, double-blind, placebo-controlled, crossover trial involving healthy Japanese adults (n = 30) reported that supplementation with 200 mg/day of L-theanine for four weeks was associated with a significant reduction in participant-reported mood and anxiety symptoms relative to baseline that did not occur during the placebo condition, though between group analyses showed only”
From Effects of L-theanine on cognition, mood and sleep: evidence from human trials (2026) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These studies have also reported this dosing range of L-theanine to be safe and well-tolerated.”
From Effects of L-theanine on cognition, mood and sleep: evidence from human trials (2026) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Overall, trials have indicated that supplementation with 200–400 mg/day of L-theanine can help to reduce both perceived and physiological markers of stress and anxiety in largely healthy adult samples, particularly during periods of acute stress.”
From Effects of L-theanine on cognition, mood and sleep: evidence from human trials (2026) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similar improvement of sleep was observed in healthy participants' sleep disturbance shown as decreased scores of PSQI (P = 0.030) [8], as well as in participants diagnosed with GAD [4].”
From How does the tea L-theanine buffer stress and anxiety (2022) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Other studies examining l-theanine have also shown improvements in markers of stress among healthy populations in acute [9, 10] and chronic [11, 12] settings.”
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007) · Behavior Research Methods · doi:10.3758/bf03193146 · Cited by 65,971 · cited 2×
“The sample size was determined by using G*Power software (3.1 version, Franz Faul, University of Kiel, Kiel, Germany) [41,42].”
InfluentialStatistical power analyses using G∗Power 3.1: tests for correlation and regression analyses
Faul, F., Erdfelder, E., Buchner, A., & Lang, A.-G. (2009) · Behavior Research Methods · doi:10.3758/brm.41.4.1149 · Cited by 37,615 · cited 2×
“The sample size was determined by using G*Power software (3.1 version, Franz Faul, University of Kiel, Kiel, Germany) [41,42].”
InfluentialThe Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234 · cited 8×
“The SDS, STAI-trait (T), and PSQI scores were significantly improved after L-theanine administration (p = 0.019, 0.006, and 0.013, respectively; Figure 1).”
MethodInfluential(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
Studies of interference in serial verbal reactions
Stroop, J. R. (1935) · Journal of Experimental Psychology · doi:10.1037/h0054651 · Cited by 18,622
Cook, R. J., Dickens, B. M., & Fathalla, M. F. (2003) · Reproductive Health and Human Rights · doi:10.1093/acprof:oso/9780199241323.003.0025 · Cited by 10,769
(1998) · PubMed · Cited by 10,216
Keefe, R. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2003.09.011 · Cited by 1,573 · cited 1×
“Cognitive functions were evaluated by a research psychiatrist using the Trail-Making Test [57], the Stroop test [58], and the Japanese version of the Brief Assessment of Cognition in Schizophrenia (BACS) [59,60].”
Method
Research works printed but not linked: 1
- Spielberg C.D. STAI Manual Consulting Psychologists Press Palo Alto, CA, USA 1970
Cited by
Items 101–156 of 156
Ter-Antonyan, V., Kikendall, C., Harris, C., & Davis, J. (2025) · Journal of Traditional Medicine & Applications · doi:10.33140/jtma.04.02.07 · Cited by 1
Lee, J., Kim, D. H., Park, S. J., Jong, H. R., Jung, J. W., Jeon, Y., Park, S.-R., Kim, G., & Lee, S. (2021) · Applied Animal Behaviour Science · doi:10.1016/j.applanim.2021.105487 · Cited by 2
Indonesia, U., Sugito, S. K., Cristina, A. U., Indonesia, U., Harimurti, P. S., Indonesia, U., Cendani, G. R., Indonesia, U., Insani, F. A., Indonesia, U., et al. (2023) · Indonesian Journal of Medical Chemistry and Bioinformatics · doi:10.7454/ijmcb.v1i2.1006 · Cited by 1
Harnessing Photosynthetic ATP for Whole-Cell Biocatalysis in the Cyanobacterium Synechocystis
Loprete, G., Traverso, E., Vascon, F., Botteri, M., Robescu, M. S., Ubiali, D., Cendron, L., Morosinotto, T., & Bergantino, E. (2025) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.5c07236 · Cited by 2
Deshpande, S. S., Kurdi, M., Baiju, A., Athira, A. S., Sarasamma, A. G., & Gangadharan, A. K. (2025) · Journal of Anaesthesiology Clinical Pharmacology · doi:10.4103/joacp.joacp_417_23 · Cited by 1
Zhang, R., Jiang, B., Xiang, L., Zhou, L., & Xiao, Z. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107601 · Cited by 1
Biomedical engineering applications of tea and its derivatives
Shao, N., Liang, H., Wang, S., Lin, G., Jin, H., Lei, L., & Li, Y. (2025) · Materials & Design · doi:10.1016/j.matdes.2025.115129 · Cited by 2
Watanabe, T., Kurosaka, S., Namatame, Y., & Kawahara, T. (2025) · Life · doi:10.3390/life16010026 · Cited by 6
“…for their sleep benefits, including γ -aminobutyric acid (GABA), which may facilitate sleep onset and improve sleep architecture [10]; L-theanine, which exerts relaxation effects [11]; and fermented milk or probiotics, which have been linked to improvements in sleep-related indices [12,13].”
Gong, J., Jia, X., Wang, L., Yiwu, L., Guo, R., Ruihan, G., Jingyu, H., Zifu, Z., Duan, S., Liu, X., et al. (2026) · Food & Function · doi:10.1039/d5fo03867g · Cited by 2
Bulman, A., McKune, A., Georgousopoulou, E., Sergi, D., & Naumovski, N. (2026) · Contemporary Clinical Trials · doi:10.1016/j.cct.2026.108306 · Cited by 1
Brewer‐Smyth, K. (2022) · Springer eBooks · doi:10.1007/978-3-031-08801-8_12 · Cited by 3
Theanine (L-gamma-glutamylethylamide) in green tea, and its impact on cognitive function
Baba, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14158-4.00023-3 · Cited by 1
Utley, A. (2023) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2023.49.007746
Type of Tea Consumption and Depressive Symptoms in Older AdultsPreprint
Yao, Y., Chen, H., Chen, L., Ju, S.-Y., Yang, H., Zeng, Y., Gu, D., & Ng, T. P. (2020) · Research Square · doi:10.21203/rs.3.rs-104524/v1 · Cited by 1
Konno, H., Murotani, R., & Kamada, Y. (2023) · medRxiv · doi:10.1101/2023.10.01.23296182 · Cited by 2
Effects of L-theanine on cognition, mood and sleep: evidence from human trials
Cotter, J., & Kilpatrick, H. E. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1922819
Wendt, J. A., Considine, C., & Kogan, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-81758-9_8
Wendt, J. A., Considine, C., & Kogan, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-81758-9_4
Alpha casozepine and L-theanine in ameliorating stress levels in infertile couples: a review
Ahire, P., Stalin, C., & Saha, S. (2023) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20230844
ประสิทธิผลของน้ำตาลลำไยต่อการเพิ่มคุณภาพการนอนหลับในอาสาสมัครที่มีภาวะนอนไม่หลับ
หัตถโกศล, ฉ., ลับแล, ศ., เตชะวิเชียร, ม., ทับเจริญ, ญ., ทรัพย์วโรบล, ส., สรรพ่อค้า, พ., & โตรักษา, ส. (2023) · Ramathibodi Medical Journal · doi:10.33165/rmj.2023.46.2.261723
Exchanges between the gastrointestinal system and the brain
Robinson, L. B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89827-0.00003-6
Gutiérrez-Romero, S. A., Torres-Narváez, E. S., Zamora, A. C., Castillo-Castillo, S., Latorre-Velásquez, A. L., Betancourt-Villamizar, C., & Mendivil, C. O. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4592091
Benefits of l-theanine supplementation and its possible role in clinical use – review
Womperski, K., Woźniak, J., Szymonik, J., Szopa, S., & Elias, J. (2024) · Quality in Sport · doi:10.12775/qs.2023.16.001 · Cited by 1
Li, Y., Yang, Q., Wang, X., et al. (2024) · Iranian Journal of Public Health · doi:10.18502/ijph.v53i6.15905
Chronic insomnia and ways to overcome it
Mishchenko, T. S., Забродіна, Л. П., Mishchenko, V. М., & Bovt, Y. V. (2024) · Psychiatry Neurology and Medical Psychology · doi:10.26565/2312-5675-2024-23-03
Theanine and amelioration of brain stress
Unno, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14158-4.00079-8
Theanine (l-glutamylethylamide) in tea and its protective effects against bladder dysfunction
Matsuoka, K., Akaihata, H., Hata, J., Tanji, R., Ogawa, S., & Kojima, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14158-4.00050-6
Self-citationL-theanine promotes angiogenesis in limb ischemic mice by modulating NRP1/VEGFR2 signaling
Wang, J., Xu, Y., Ruan, Y.-E., & Hu, X. (2025) · Biomolecules and Biomedicine · doi:10.17305/bb.2024.11256 · Cited by 1
“These properties enable it to exert a range of physiological effects, including the modulation of immunity [18], enhancement of cognitive function [19, 20], and antioxidant activity [21].”
Karmase, A., Agarwal, A., Joshi, P., Sethi, S., & Shrivastava, A. (2025) · Cosmoderma · doi:10.25259/csdm_208_2024
Bruti, G., Giacomo, P. D., Pratesi, A., & Paolo, C. D. (2025) · Cureus · doi:10.7759/cureus.79303
“Interestingly, the authors of this latter study used the same psychometric tools to assess the clinical outcome variables that we included in our study, such as PSQI, STAI-Y1/Y2, and a self-administered rating scale for depressive symptoms (Table 3 ) [24].”
Effect of L-Theanine on Cerebellar Granule Cell Migration Related to Cognitive DisordersPreprint
Ibrahim, M., Matsuda, T., Kuriya, K., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5146758
Self-citationSupplements for Enhancing the Quality of Sleep: A Review
Dolepski, K., Duszyńska, K., Góral, A., Żuk, K., & Czachajda, M. (2024) · Journal of Health Study and Medicine · doi:10.2478/jhsm-2024-0013
Lombardo, C. (2024) · International Journal of Women’s Health Care · doi:10.33140/ijwhc.09.03.01
The role of nutraceuticals of natural origin in the treatment of depressive disorders
Sęk, M., Galasińska, I., Hajduk-Maślak, K., Michalik, B., Skóra, A., & Zając, D. (2025) · Journal of Education Health and Sport · doi:10.12775/jehs.2025.82.60309
“Additionally, theanine, a prominent amino acid found in green tea, has demonstrated anti-stress effects [44,45].”
Nutrition and Sleep: Dietary Influences on Rest
Juginović, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-92060-8_6
Rithanya, M., J, U. D., & Mohanraj, K. G. (2025) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2025v18i7.54933
Dietary Supplements for Performance Enhancement in Esports
Bayram, H. M., Rogers, E. J., & Arslan, S. (2025) · Springer eBooks · doi:10.1007/978-3-031-99625-2_6
McRoberts, A. J., & Martin, B. R. (2025) · Journal of Chiropractic Medicine · doi:10.1016/j.jcm.2025.09.018
Yamaura, S., Kawada, K., Uno, K., Konishi, R., Mukai, A., Tada, S., Okada, H., Majima, T., Komori, K., Kuramoto, N., et al. (2026) · Journal of Pharmaceutical Health Care and Sciences · doi:10.1186/s40780-026-00562-6
Noreen, S., Khalid, Z., Hassan, A., Sultan, H., Fatima, M., & Aja, P. M. (2026) · CyTA - Journal of Food · doi:10.1080/19476337.2026.2659406
Clinical Evaluation of an NVTIA 5-HTP-L-Theanine-GABA Sleep Rhythm Support System
Yassine, J., Semenza, G. L., & Bishop, A. (2026) · Scientific Journal of Technology · doi:10.54691/wa60tw61
“In a double-blind crossover trial in 30 healthy adults, 200 mg/day of L-theanine for 4 weeks reduced Pittsburgh Sleep Quality Index scores and improved the sleep-latency, sleep-disturbance, and sleep-medication-use subscales versus placebo [5].”
Nawathe, V. A., Verma, S., Pal, A., Pawar, D., & Sharma, A. (2026) · Cureus · doi:10.7759/cureus.108032 · Cited by 1
“In addition, an RCT on L-theanine demonstrated improved sleep quality (p = 0.013) and enhanced cognitive functions such as verbal fluency (p = 0.001) and executive function (p = 0.031) [162].”
InfluentialDworak, M., & Hüsing, A. (2026) · Springer eBooks · doi:10.1007/978-3-662-72729-4_5
Sahin, K., & Erek, G. (2026) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188261451345
“68,71,72 76 Beyond the CNS, L-theanine engages antioxidant and immunomodulatory pathways that are highly relevant to CVS. Experimental studies demonstrate activation of Nrf2-dependent transcriptional programs, upregulation of endogenous antioxidant enzymes (SOD, CAT, GSH-Px), and suppression of…”
InfluentialSleep in the Professional Baseball Player
Nobleza, D., Cordero, A., Ferry, C., MacNeill, S., & Kass, L. J. (2026) · Advances in Psychiatry and Behavioral Health · doi:10.1016/j.ypsc.2026.04.001
Morais, Y. B., de Morais, M. F., Freitas, M. C., Craveiro, R. M. C. B., de Andrade, I. P., Felix, L. D. C., Chaves, E. M. C., Assreuy, A. M. S., & Aragão, G. F. (2026) · Brazilian Archives of Biology and Technology · doi:10.1590/1678-4324-2026250069
Zhao, H., & Wu, W. (2026) · Nutrients · doi:10.3390/nu18132185
“L-theanine can cross the blood–brain barrier, increasing brain levels of GABA, dopamine, 5-HT, and other neurotransmitters, thereby exerting relaxation, anxiety relief, and sleep improvement effects [139].”
Gérolymos, C., Saddier, E., Boyer, L., & Fond, G. B. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03727-9 · Cited by 1
Gogate, S., Nanaware, S. S., & Padma, K. (2026) · Indian Journal of Medical Specialities · doi:10.4103/injms.injms_8_26
Wang, Q. Y., Yu, J., Mao, P., Ge, S., Bai, P., Ahammed, G. J., Li, Z., Yang, F., Zhai, D., Shi, K., et al. (2026) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiag543
Yu, S., Feng, J., Zhou, G., Xiao, C., Wang, Y., Li, W., Gao, Y., Xl, W., Zhang, L., & Li, P. (2026) · Plant Biology · doi:10.1111/plb.70262
“2015; Hidese et al .”
Alanazi, A., Alanzi, R., & Abdo, A. A. A. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1925871
Zhao, G.-H., Tian, S.-Y., Li, Y.-H., Dong, W.-X., Jiang, H., Kuang, J.-X., Wang, F.-A., Li, S.-J., & Li, Y. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.181930
Lomiwes, D. D., Günther, C. S., Kanon, A. P., Lo, K., Scholey, A. B., Ngametua, N., Trower, T. M., Walker, E. G., Jensen, D. A., & Cooney, J. M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1896655
“…reported to promote relaxation without drowsiness, with both clinical and pre-clinical research demonstrating its efficacy in improving mood through the modulation of central monoaminergic and glutamatergic neurotransmitter signalling (Nathan et al., 2006; White et al., 2016; Hidese et al., 2019).”
Mastrofini, G. F., Romersi, R. F., Lombardi, M. G., Persaud, K. T., Ryan, M. M., Hirsch, K. R., Fraley, A. L., Dawes, J. J., Stray-Gundersen, S. O., Hardin, J. W., et al. (2026) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2026.2740227
“Acute supplementation of 200 mg L-theanine reduced the stress response during an experimental stress task [32], while four weeks of 200 mg supplementation reduced subjective stress and subscales of the PSQI [33].”
Matcha (Japanese ground green tea) and cognitive function
Lange, K. W., & NAKAMURA, Y. (2026) · Journal of Food Bioactives · doi:10.26599/jfb.2026.95035451 · Cited by 1
Metadata
- Authors
- Hidese, S., Ogawa, S., Ota, M., Ishida, I., Yasukawa, Z., Ozeki, M., & Kunugi, H.
- Affiliations
- National Center of Neurology and Psychiatry (JP)
- Taiyo Kagaku Co., Ltd. (Japan) (JP)
- Corresponding author
- Kunugi, Hiroshi
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-10-03
- Volume
- 11
- Issue
- 10
- Pages
- 2362
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6836118
- OpenAlex
- W2977908783
- Semantic Scholar
- a77bb6ac85035be83ec02a7b6eee6ea31c929676
- Cited by
- 170
- References
- 65
- Citations by year
- 2026: 32 · 2025: 38 · 2024: 34 · 2023: 23 · 2022: 18 · 2021: 17 · 2020: 8
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- Funders
- Funding received from Taiyo Kagaku Co., Ltd., Mie, Japan. (None)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plant Extracts Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- theanine, stress-related symptoms, cognitive function, depression, anxiety, sleep quality, sleep latency, sleep disorders, sleep medication use, verbal fluency, phonemic fluency, executive function, healthy adults, mental health
- MeSH terms
- Adult, Anxiety, Cognition, Depression, Double-Blind Method, Female, Glutamates, Humans, Male, Middle Aged, Placebos, Sleep Wake Disorders, Stress, Psychological, Body Mass Index, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.